Drug Type Small molecule drug |
Synonyms Compound 4f |
Target |
Action inhibitors |
Mechanism MAGL inhibitors(Monoglyceride lipase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21ClN2O4 |
InChIKeyAKBHYCHPWZPGAH-QGGXVJLZSA-N |
CAS Registry2135785-20-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neurodegenerative Diseases | Preclinical | Japan | 06 Oct 2021 |